Freshfields
Jon Scurr
- Deals
- 2
- Latest
- Sep 2026
- Most deals in
- Pharma
Firm
- Freshfields Law firm · 2026 · 2 deals
Often works with
- Jennifer Bethlehem 1 deal together
- Katie Stenstrom 1 deal together
- Jeff Jay 1 deal together
- Ben Cohen 1 deal together
- Emily Parfitt 1 deal together
- Jimmy Cao 1 deal together
- Wolfgang Paulson 1 deal together
Deals
US deals dated after 30 September 2026 are still being collected.
Columns
| Sep 2026 | portfolio of 20 mature medicines and three manufacturing sites | Sanofi | Cheplapharm | Asset sale | Legal adviser to Sanofi (seller) | Announced | – | Pharma+1 | Cheplapharm acquisition of portfolio of 20 mature medicines and three manufacturing sites |
| May 2026 | Exclusive development and commercialisation rights to Idefirix in Europe and MENA | Hansa Biopharma AB | SERB Pharmaceuticals | Asset sale | Legal adviser to SERB Pharmaceuticals (acquirer) | Pending | 133.6 | Pharma+1 | SERB Pharmaceuticals acquisition of Exclusive development and commercialisation rights to Idefirix in Europe and MENA |
Deals where Jon Scurr is named on the firm's deal team, by the firm or the press.